Calcium Channel Agonist

Calcium Channel Agonists (19):

Cat. No.	Product Name	Effect	Purity

HY-B0106A

Etiracetam	Agonist	99.91%
Etiracetam (UCB 6474) is an acetylcholine agonist and a nootropic drug of the racetam family. Less active than its S-enantiomer Levetiracetam (UCB L059).

HY-10588

Bay K 8644	Agonist	99.96%
Bay K 8644 ((±)-Bay K 8644) is a racemate consisting of two isomers (R)-(+)-Bay-K-8644 and (S)-(-)-Bay-K-8644. Bay K 8644 is a L-type Ca²⁺ channel agonist with an EC₅₀ of 17.3 nM. Bay K 8644 increases Ca²⁺ influx through sarcolemmal Ca²⁺ channels by increasing the open time of the channel. Bay K 8644 has vasoconstrictive effects.

HY-113308A

Taurolithocholic acid sodium salt	Agonist	99.81%
Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca²⁺ agonist.

HY-15124

(S)-(-)-Bay-K-8644	Agonist	98.81%
(S)-(-)-Bay-K-8644 is an agonist of L-type Ca²⁺ channel. (S)-(-)-Bay-K-8644 activates Ba²⁺ currents (I_Ba) (EC₅₀=32 nM).

HY-103307

FPL64176	Agonist	99.81%
FPL64176, a nondihydropyridine compound, is a potent agonist of L-type Ca²⁺ channels with an EC₅₀ value of 16 nM.

HY-12498

GV-58	Agonist	99.22%
GV-58 is a novel N- and P/Q-type calcium (Ca²⁺) channel agonist with EC₅₀s of 7.21 and 8.81 μM, respectively. GV-58 slows the deactivation of channels, resulting in a large increase in presynaptic Ca²⁺ entry during activity. GV-58 can be used in lambert-eaton myasthenic syndrome (LEMS) research.

HY-41076

Ca2+ channel agonist 1	Agonist	99.71%
Ca²⁺ channel agonist 1 is an agonist of N-type Ca²⁺ channel and an inhibitor of Cdk2, with EC₅₀s of 14.23 μM and 3.34 μM, respectively, and is used as a potential treatment for motor nerve terminal dysfunction.

HY-P5114

Maurocalcine	Agonist
Maurocalcine is an agonist of ryanodine receptor (RyR) channel types 1, 2 and 3 with cellular permeability. Maurocalcine induces [³H]ryanodine binding on RyR1 with an EC₅₀ value of 2558 nM. Maurocalcine exhibits a apparent affinity of 14 nM for RyR2. Maurocalcine can be applied to in vivo cell tracking or other cell imaging techniques.

HY-P5114A

Maurocalcine TFA	Agonist
Maurocalcine TFA is an agonist of ryanodine receptor (RyR) channel types 1, 2 and 3 with cellular permeability. Maurocalcine TFA induces [³H]ryanodine binding on RyR1 with an EC₅₀ value of 2558 nM. Maurocalcine TFA exhibits a apparent affinity of 14 nM for RyR2. Maurocalcine TFA can be applied to in vivo cell tracking or other cell imaging techniques.

HY-113308AS

Taurolithocholic acid-d₄ sodium	Agonist
Taurolithocholic acid-d₄ (sodium) is the deuterium labeled Taurolithocholic acid (sodium salt). Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1].

HY-113308AS2

Taurolithocholic acid-d₄-1 sodium	Agonist
Taurolithocholic acid-d₄-1 (sodium) is the deuterium labeled Taurolithocholic acid. Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1].

HY-119581

MBED	Agonist
MBED (9-Methyl-7-bromoeudistomin D) is a RyR agonist. MBED is a high-affinity caffeine-like probe, helps identify the caffeine-binding site in RyRs.

HY-113308S

Taurolithocholic acid-d₅	Agonist
Taurolithocholic acid-d₅ is deuterium labeled Taurolithocholic acid.

HY-113308S1

Taurolithocholic acid-d₄	Agonist
Taurolithocholic acid-d₄ is deuterium labeled Taurolithocholic acid.

HY-B0106AR

Etiracetam (Standard)	Agonist
Etiracetam (Standard) is the analytical standard of Etiracetam. This product is intended for research and analytical applications. Etiracetam (UCB 6474) is an acetylcholine agonist and a nootropic drug of the racetam family. Less active than its S-enantiomer Levetiracetam (UCB L059).

HY-B0106AS

Etiracetam-d₃	Agonist
Etiracetam-d₃ is the deuterium labeled Etiracetam. Etiracetam (UCB 6474) is an acetylcholine agonist and a nootropic drug of the racetam family. Less active than its S-enantiomer Levetiracetam (UCB L059)[1].

HY-113308AS1

Taurolithocholic Acid-d₅ sodium	Agonist
Taurolithocholic Acid-d₅ (sodium) is the deuterium labeled Taurolithocholic acid sodium salt. Taurolithocholic acid sodium salt, a potent cholestatic agent, is a potent Ca2+ agonist[1][2].

HY-106927

Bay Y5959	Agonist
Bay Y5959 is a potent calcium channel agonist. Bay Y5959 binds to the DHP receptor in a voltage-dependent manner increases both the mean open time and the mean closed time of the Ca-channel. Bay Y5959 has the potential for the research of congestive heart failure, arrhythmic.

HY-120535

RS 30026	Agonist
RS 30026 is a potent calcium channel agonist with a pEC₅₀ value of 7.45.

Name
Email *

	Sorry, but the email address you supplied was invalid.